Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy. | BMC Biol | 2025 | 39871281 | PubTator, text mining | PubMed |
| Multiple Myeloma Cells Shift the Fate of Cytolytic ILC2s Towards TIGIT-Mediated Cell Death. | Cancers (Basel) | 2025 | 39858045 | PubTator, text mining | PubMed |
| Enhanced co-expression of TIGIT and PD-1 on γδ T cells correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome. | Clin Rheumatol | 2025 | 39856468 | PubTator, text mining | PubMed |
| Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia. | Mol Oncol | 2025 | 39777847 | PubTator, text mining | PubMed |
| Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells. | Cell Rep | 2025 | 39754720 | PubTator, text mining | PubMed |
| The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activation. | Exp Hematol | 2025 | 39694409 | PubTator, text mining | PubMed |
| Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions That Instructs Intratumoral γδT-cell Activity. | Cancer Res | 2025 | 39514370 | PubTator, text mining | PubMed |
| 1D, 3D supramolecular assemblies of a series of cyclometalated platinum(II) complexes with deep-red aggregation-induced phosphorescent emission and anion turn-on sensing via Pt-Pt interaction. | Biosens Bioelectron | 2025 | 39504886 | PubTator, text mining | PubMed |
| Expression of CD226 on γδ T cells is lower in advanced chronic lymphocytic leukemia and correlates with IgA, IgG and LDH levels. | Adv Clin Exp Med | 2025 | 38819939 | PubTator, text mining | PubMed |
| Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. | Hepatology | 2025 | 38779918 | PubTator, text mining | PubMed |
| The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer. | Front Immunol | 2024 | 39835114 | PubTator, text mining | PubMed |
| Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease. | Front Microbiol | 2024 | 39764446 | PubTator, text mining | PubMed |
| Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model. | Heliyon | 2024 | 39687194 | PubTator, text mining | PubMed |
| Statistical methods for comparing two independent exponential-gamma means with application to single cell protein data. | PLoS One | 2024 | 39671382 | PubTator, text mining | PubMed |
| Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager. | iScience | 2024 | 39628574 | PubTator, text mining | PubMed |
| Exercise: a non-drug strategy of NK cell activation. | Braz J Med Biol Res | 2024 | 39607207 | PubTator, text mining | PubMed |
| Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity. | Sci Rep | 2024 | 39506082 | PubTator, text mining | PubMed |
| TGF-β-mediated crosstalk between TIGIT+ Tregs and CD226+CD8+ T cells in the progression and remission of type 1 diabetes. | Nat Commun | 2024 | 39406740 | PubTator, text mining | PubMed |
| Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2. | Exp Mol Med | 2024 | 39349829 | PubTator, text mining | PubMed |
| CD226 implicated in Akt-dependent apoptosis of CD4+ T cell contributes to asthmatic pathogenesis. | Cell Death Dis | 2024 | 39349422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=11